Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387378321> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W4387378321 endingPage "101814" @default.
- W4387378321 startingPage "101814" @default.
- W4387378321 abstract "Potassium iodide (KI) is a treatment to neutralize radioactive agents that could be inhaled or ingested in nuclear incidents. The inorganic salt KI constitutes a source of iodine, which in the body acts by accumulating in the thyroid gland, producing its saturation, and thus preventing the fixation of radioactive iodine species. In Spain, the Military Defence Pharmacy Centre (CEMILFARDEF) was challenged to develop this antidote to be distributed among the population surrounding nuclear power plants, in only one new solid pharmaceutical form for oral administration, in order to replace the two pharmaceutical forms available, which are capsules for adults and oral solution for children, considered less versatile. A selection of excipients was carried out to achieve pharmacotechnical behaviour suitable for the industrial manufacture of potassium iodide in tablets, complying with the pre-established process and finished product quality parameters. The development allowed the preparation of three industrial-sized batches on which the stability of the developed formulation was studied. An uncoated 65 mg double-scored potassium iodide tablet was developed using easily accessible excipients in the formulation and direct compression as the manufacturing method. The formula complied with the stability tests, with which the development carried out can respond to the eventual demand that its elaboration would entail in the event of nuclear incidents. The developed formulation of a 65 mg double-scored potassium iodide tablet allows the great variability of user needs, from infants to adults with a single pharmaceutical form, which additionally implies logistical benefits in distribution, stock control and appropriate renewal according expiration dates, among the population surrounding nuclear power plants and available to deployed military personnel, in the event of potential nuclear incidents." @default.
- W4387378321 created "2023-10-06" @default.
- W4387378321 creator A5001514504 @default.
- W4387378321 creator A5026701538 @default.
- W4387378321 creator A5034769323 @default.
- W4387378321 creator A5035985271 @default.
- W4387378321 creator A5084456424 @default.
- W4387378321 date "2023-10-01" @default.
- W4387378321 modified "2023-10-16" @default.
- W4387378321 title "Development of a formulation of potassium iodide tablets as an antidote against nuclear incidents" @default.
- W4387378321 cites W1967165944 @default.
- W4387378321 cites W1985653410 @default.
- W4387378321 cites W1991160303 @default.
- W4387378321 cites W1992585082 @default.
- W4387378321 cites W1996270935 @default.
- W4387378321 cites W2005428968 @default.
- W4387378321 cites W2012191220 @default.
- W4387378321 cites W2045569037 @default.
- W4387378321 cites W2081262514 @default.
- W4387378321 cites W2092699910 @default.
- W4387378321 cites W2125835707 @default.
- W4387378321 cites W2152607324 @default.
- W4387378321 cites W2165200917 @default.
- W4387378321 cites W2322427050 @default.
- W4387378321 cites W2503988581 @default.
- W4387378321 cites W2504795581 @default.
- W4387378321 cites W2560261273 @default.
- W4387378321 cites W2994725018 @default.
- W4387378321 cites W3161367626 @default.
- W4387378321 cites W4212819473 @default.
- W4387378321 cites W4212881206 @default.
- W4387378321 cites W4224865981 @default.
- W4387378321 cites W4281655331 @default.
- W4387378321 cites W4313704289 @default.
- W4387378321 doi "https://doi.org/10.1016/j.jsps.2023.101814" @default.
- W4387378321 hasPublicationYear "2023" @default.
- W4387378321 type Work @default.
- W4387378321 citedByCount "0" @default.
- W4387378321 crossrefType "journal-article" @default.
- W4387378321 hasAuthorship W4387378321A5001514504 @default.
- W4387378321 hasAuthorship W4387378321A5026701538 @default.
- W4387378321 hasAuthorship W4387378321A5034769323 @default.
- W4387378321 hasAuthorship W4387378321A5035985271 @default.
- W4387378321 hasAuthorship W4387378321A5084456424 @default.
- W4387378321 hasBestOaLocation W43873783211 @default.
- W4387378321 hasConcept C178790620 @default.
- W4387378321 hasConcept C185592680 @default.
- W4387378321 hasConcept C2778870691 @default.
- W4387378321 hasConcept C2780584464 @default.
- W4387378321 hasConcept C31903555 @default.
- W4387378321 hasConcept C539932907 @default.
- W4387378321 hasConcept C71924100 @default.
- W4387378321 hasConcept C77281830 @default.
- W4387378321 hasConcept C98274493 @default.
- W4387378321 hasConceptScore W4387378321C178790620 @default.
- W4387378321 hasConceptScore W4387378321C185592680 @default.
- W4387378321 hasConceptScore W4387378321C2778870691 @default.
- W4387378321 hasConceptScore W4387378321C2780584464 @default.
- W4387378321 hasConceptScore W4387378321C31903555 @default.
- W4387378321 hasConceptScore W4387378321C539932907 @default.
- W4387378321 hasConceptScore W4387378321C71924100 @default.
- W4387378321 hasConceptScore W4387378321C77281830 @default.
- W4387378321 hasConceptScore W4387378321C98274493 @default.
- W4387378321 hasLocation W43873783211 @default.
- W4387378321 hasOpenAccess W4387378321 @default.
- W4387378321 hasPrimaryLocation W43873783211 @default.
- W4387378321 hasRelatedWork W126352917 @default.
- W4387378321 hasRelatedWork W1982508727 @default.
- W4387378321 hasRelatedWork W1985633291 @default.
- W4387378321 hasRelatedWork W1990491372 @default.
- W4387378321 hasRelatedWork W2003107470 @default.
- W4387378321 hasRelatedWork W2078985763 @default.
- W4387378321 hasRelatedWork W2093860530 @default.
- W4387378321 hasRelatedWork W2158279933 @default.
- W4387378321 hasRelatedWork W2423522576 @default.
- W4387378321 hasRelatedWork W3029570087 @default.
- W4387378321 isParatext "false" @default.
- W4387378321 isRetracted "false" @default.
- W4387378321 workType "article" @default.